Today: 15 March 2026
Subscribe
Browse Category

Stock Market 13 December 2025

Coherent Corp. (COHR) Stock This Week: Bain Capital Block Sale Sparks 10% Drop—Latest News, Analyst Forecasts, and Week-Ahead Setup (Updated Dec. 12, 2025)

Coherent Corp. (COHR) Stock This Week: Bain Capital Block Sale Sparks 10% Drop—Latest News, Analyst Forecasts, and Week-Ahead Setup (Updated Dec. 12, 2025)

Coherent Corp. shares fell about 10% Friday to $178.34 after Bain Capital affiliate BCPE Watson sold 5 million newly converted common shares in a $947.75 million block trade. The selloff followed a mandatory preferred-share conversion set for Dec. 15. The drop came despite strong AI datacenter demand and recent price-target hikes.
13 December 2025
·
Constellation Energy (CEG) Stock This Week: Calpine Deal Nears Closing, Nuclear “Data Economy” Tailwinds, and What Investors Watch Next Week (Updated Dec. 12, 2025)

Constellation Energy (CEG) Stock This Week: Calpine Deal Nears Closing, Nuclear “Data Economy” Tailwinds, and What Investors Watch Next Week (Updated Dec. 12, 2025)

Constellation Energy shares fell 7.03% Friday, closing at $351.98 after an early surge to $380.78 reversed sharply. The drop erased gains from earlier in the week, leaving the stock down 1.6% from Monday’s close. The moves follow news that Constellation cleared its final regulatory hurdle for the $16.4 billion Calpine acquisition, including DOJ and FERC-mandated divestitures. Trading volume Friday reached 3.78 million shares.
13 December 2025
···
Pfizer Stock (PFE) Outlook: GLP‑1 Weight‑Loss Deal, Tukysa Trial Win, Dividend Declared — and the Big Catalyst Next Week (Updated Dec. 12, 2025)

Pfizer Stock (PFE) Outlook: GLP‑1 Weight‑Loss Deal, Tukysa Trial Win, Dividend Declared — and the Big Catalyst Next Week (Updated Dec. 12, 2025)

Pfizer shares closed at $25.85 Friday, up 0.19%, after announcing a global obesity drug deal with YaoPharma and reporting positive Phase 3 data for breast cancer drug Tukysa. The company also highlighted strong hemophilia trial results and declared a $0.43 per share dividend, payable March 6, 2026. Trading volume reached about 23 million shares.
13 December 2025
···
CrowdStrike (CRWD) Stock Update: This Week’s Volatility, Fresh News Catalysts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

CrowdStrike (CRWD) Stock Update: This Week’s Volatility, Fresh News Catalysts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

CrowdStrike closed Friday at $504.78, down 2.49% and marking a second straight daily decline. The stock is now nearly 11% below its November 52-week high as tech shares broadly retreated. Trading volume rose to about 2.6 million, above average. CrowdStrike’s year-to-date gain stands at 47.53%, with a market cap near $130.5 billion.
13 December 2025
·
KLA Corporation Stock (KLAC) This Week & Week Ahead: Latest News, Analyst Forecasts, and Key Catalysts (Updated Dec. 12, 2025)

KLA Corporation Stock (KLAC) This Week & Week Ahead: Latest News, Analyst Forecasts, and Key Catalysts (Updated Dec. 12, 2025)

KLA Corporation shares fell 4.19% to $1,193.92 on Friday, Dec. 12, ending a five-day rally amid a broader tech selloff. The drop followed negative headlines for Oracle and Broadcom, which fueled investor concerns over AI spending and valuations. KLAC remains about 7% below its all-time high of $1,284.47. The stock finished the week down 1.7%.
13 December 2025
··
Warner Bros. Discovery (WBD) Stock Jumps Toward $30 on Netflix Deal and Paramount Counterbid — Outlook for Next Week (Updated Dec. 12, 2025)

Warner Bros. Discovery (WBD) Stock Jumps Toward $30 on Netflix Deal and Paramount Counterbid — Outlook for Next Week (Updated Dec. 12, 2025)

Warner Bros. Discovery closed Friday at $29.98, just below Paramount Skydance’s $30.00-per-share all-cash tender offer. The stock moved higher after Paramount launched its bid, challenging Netflix’s $27.75-per-share agreement for WBD’s studios and streaming assets. A federal lawsuit was filed this week seeking to block the Netflix deal. WBD’s board has not yet responded to Paramount’s offer.
13 December 2025
····
Home Depot Stock (HD) Weekly Update: Investor Day Outlook, New Headlines, and What to Watch Next Week (Updated Dec. 12, 2025)

Home Depot Stock (HD) Weekly Update: Investor Day Outlook, New Headlines, and What to Watch Next Week (Updated Dec. 12, 2025)

Home Depot shares closed at $359.65 on Friday, Dec. 12, up 2.8% for the week after rebounding from early losses tied to cautious 2026 guidance at its Investor and Analyst Conference. Management projected modest sales and earnings growth for fiscal 2026, with a more optimistic scenario dependent on a housing market recovery. The company reaffirmed its 2025 outlook.
13 December 2025
·
Disney Stock (DIS) Surges This Week on $1B OpenAI Deal: Latest News, Analyst Forecasts, and Week-Ahead Catalysts (Updated Dec. 12, 2025)

Disney Stock (DIS) Surges This Week on $1B OpenAI Deal: Latest News, Analyst Forecasts, and Week-Ahead Catalysts (Updated Dec. 12, 2025)

Disney shares jumped nearly 6% this week, closing Friday at $111.60 after a late surge tied to AI news. The company announced a $1 billion investment and character licensing deal with OpenAI, allowing its IP in Sora video tools. Shares traded between $104.83 and $113.34. The agreement includes guardrails on character use and gives Disney access to OpenAI’s technology.
13 December 2025
···
Johnson & Johnson Stock (JNJ) Jumps Near 52-Week Highs on FDA Approval and Oncology Data — Week in Review, Week Ahead (Updated Dec. 12, 2025)

Johnson & Johnson Stock (JNJ) Jumps Near 52-Week Highs on FDA Approval and Oncology Data — Week in Review, Week Ahead (Updated Dec. 12, 2025)

Johnson & Johnson shares closed at $211.58 on Dec. 12, 2025, up 4.9% for the week after an FDA approval for AKEEGA in prostate cancer and new multiple myeloma data. The stock outperformed the broader market despite renewed talc litigation risk. A Federal Reserve rate cut earlier in the week supported large healthcare stocks. JNJ traded as high as $212.27 intraday Friday.
13 December 2025
··
Procter & Gamble Stock (PG) Weekly Update: Rebound From a 52‑Week Low, Analyst Forecasts, and What to Watch Next Week (Updated Dec. 12, 2025)

Procter & Gamble Stock (PG) Weekly Update: Rebound From a 52‑Week Low, Analyst Forecasts, and What to Watch Next Week (Updated Dec. 12, 2025)

Procter & Gamble shares closed Friday at $142.84, up 1.48%, marking a fourth straight daily gain after hitting a 52-week low of $138.14 on Monday. The stock remains about 20.6% below its March peak. Volume rose above average as investors weighed weak U.S. packaged-goods demand and cautious consumer signals from recent management remarks.
13 December 2025
·
SoFi Stock (SOFI) This Week: $1.5B Share Offering Closes, New Smart Card Launch, and What to Watch Next Week (Updated Dec. 12, 2025)

SoFi Stock (SOFI) This Week: $1.5B Share Offering Closes, New Smart Card Launch, and What to Watch Next Week (Updated Dec. 12, 2025)

SoFi Technologies completed a $1.5 billion common stock offering at $27.50 per share on December 8, triggering investor concerns over dilution after a strong 2025 rally. The company also launched the SoFi Smart Card, combining checking, savings, debit, and credit features. Shares faced pressure amid the capital raise and recent product expansion.
13 December 2025
··
Seagate Technology (STX) Stock: Weekly Recap and Week-Ahead Outlook as Nasdaq-100 Inclusion Looms (Updated Dec. 12, 2025)

Seagate Technology (STX) Stock: Weekly Recap and Week-Ahead Outlook as Nasdaq-100 Inclusion Looms (Updated Dec. 12, 2025)

Seagate Technology shares fell 6.56% Friday to $287.64 after hitting a 52-week high of $308.93 Thursday. The drop came on heavy volume as tech stocks slid amid renewed “AI bubble” concerns. After the close, Nasdaq announced Seagate will join the Nasdaq-100, effective Dec. 22. Index inclusion is expected to drive trading volume and volatility in the coming week.
13 December 2025
··
Astera Labs (ALAB) Stock This Week: NVLink Fusion Headlines, Analyst Price Targets, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Astera Labs (ALAB) Stock This Week: NVLink Fusion Headlines, Analyst Price Targets, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Astera Labs (NASDAQ: ALAB) closed Friday at $148.85, down 15.3% for the week after sharp swings tied to investor debate over NVIDIA NVLink Fusion and Amazon Trainium’s impact on future AI rack designs. Shares dropped 14.3% Friday on heavy volume, with an intraday range from $146.88 to $172.49. Trading volatility followed shifting sentiment on Astera’s role in hyperscaler AI infrastructure.
13 December 2025
·
Bloom Energy (BE) Stock This Week: Why Shares Slid, Key News Drivers, Analyst Forecasts, and What to Watch Next Week (Updated Dec. 12, 2025)

Bloom Energy (BE) Stock This Week: Why Shares Slid, Key News Drivers, Analyst Forecasts, and What to Watch Next Week (Updated Dec. 12, 2025)

Bloom Energy shares fell 12.85% Friday to $94.98, capping a 19.5% weekly drop as investors pulled back from AI infrastructure stocks. The selloff followed reports of Oracle data center delays, though Oracle denied any impact on contractual milestones. Bloom remains up over 300% for 2025 despite this week’s volatility. No new company-specific news or earnings updates were issued.
13 December 2025
··
1 … 934 935 936 937 938 … 1,350

Stock Market Today

  • Investing $3,000: Comparing Bitcoin, XRP, and Gold for Diverse Portfolios
    March 15, 2026, 11:17 AM EDT. Investors with $3,000 face choices between gold, Bitcoin (BTC), and XRP, each offering distinct value storage and risk profiles. Gold, a historically stable store of value, has risen 79% in the past year, buoyed by central bank purchases and global uncertainty. Bitcoin, dubbed 'digital gold', is riskier but scarce, with supply halving events that limit future availability, potentially driving value up. XRP, another cryptocurrency, offers different dynamics but wasn't detailed here. The ideal investment depends on existing portfolio composition and risk tolerance. Diversifying across these assets allows balancing safety and growth opportunities in uncertain markets.
Go toTop